An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Clinical trial NCT03518086 · COMPLETED
Trial details
- NCT number
- NCT03518086
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-18
- Primary completion
- 2021-01-21
- Enrollment
- 1281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.